vs
富兰克林电气（FELE）与Sotera Health Co（SHC）财务数据对比。点击上方公司名可切换其他公司
富兰克林电气的季度营收约是Sotera Health Co的1.6倍（$500.4M vs $303.4M），Sotera Health Co净利率更高（11.5% vs 6.9%，领先4.6%），富兰克林电气同比增速更快（9.9% vs 4.6%），过去两年Sotera Health Co的营收复合增速更高（10.6% vs -4.0%）
富兰克林电气是全球知名的水务与能源管理产品及系统制造分销商，主营泵类、电机、驱动器及控制设备，产品广泛应用于住宅、商用、农业、工业、市政等多元场景。公司总部位于美国印第安纳州韦恩堡，在美国、德国、捷克、意大利、土耳其、墨西哥、巴西、澳大利亚、南非等多个国家设有生产基地，为全球客户提供可靠的流体运输与能源管理解决方案。
Sotera Health Co是全球领先的医疗安全解决方案提供商，面向医疗器械厂商、制药企业、食品及消费品公司提供灭菌服务、实验室分析检测与合规咨询支持，帮助客户满足监管要求，保障上市产品的使用安全。
FELE vs SHC — 直观对比
营收规模更大
FELE
是对方的1.6倍
$303.4M
营收增速更快
FELE
高出5.4%
4.6%
净利率更高
SHC
高出4.6%
6.9%
两年增速更快
SHC
近两年复合增速
-4.0%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $500.4M | $303.4M |
| 净利润 | $34.7M | $34.8M |
| 毛利率 | 35.0% | 54.7% |
| 营业利润率 | 9.6% | 23.2% |
| 净利率 | 6.9% | 11.5% |
| 营收同比 | 9.9% | 4.6% |
| 净利润同比 | 10.6% | 182.8% |
| 每股收益（稀释后） | $0.77 | $0.12 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FELESHC
| Q1 26 | $500.4M | — | ||
| Q4 25 | $506.9M | $303.4M | ||
| Q3 25 | $581.7M | $311.3M | ||
| Q2 25 | $587.4M | $294.3M | ||
| Q1 25 | $455.2M | $254.5M | ||
| Q4 24 | $485.7M | $290.2M | ||
| Q3 24 | $531.4M | $285.5M | ||
| Q2 24 | $543.3M | $276.6M |
净利润FELESHC
| Q1 26 | $34.7M | — | ||
| Q4 25 | $39.3M | $34.8M | ||
| Q3 25 | $16.7M | $48.4M | ||
| Q2 25 | $60.1M | $8.0M | ||
| Q1 25 | $31.0M | $-13.3M | ||
| Q4 24 | $33.7M | $12.3M | ||
| Q3 24 | $54.6M | $17.0M | ||
| Q2 24 | $59.1M | $8.8M |
毛利率FELESHC
| Q1 26 | 35.0% | — | ||
| Q4 25 | 33.8% | 54.7% | ||
| Q3 25 | 35.9% | 57.0% | ||
| Q2 25 | 36.1% | 56.6% | ||
| Q1 25 | 36.0% | 53.2% | ||
| Q4 24 | 33.8% | 56.6% | ||
| Q3 24 | 35.7% | 55.4% | ||
| Q2 24 | 36.8% | 55.2% |
营业利润率FELESHC
| Q1 26 | 9.6% | — | ||
| Q4 25 | 10.2% | 23.2% | ||
| Q3 25 | 14.6% | 23.4% | ||
| Q2 25 | 15.0% | 6.4% | ||
| Q1 25 | 9.7% | -5.8% | ||
| Q4 24 | 8.9% | 30.0% | ||
| Q3 24 | 13.8% | 28.2% | ||
| Q2 24 | 14.6% | 27.8% |
净利率FELESHC
| Q1 26 | 6.9% | — | ||
| Q4 25 | 7.7% | 11.5% | ||
| Q3 25 | 2.9% | 15.5% | ||
| Q2 25 | 10.2% | 2.7% | ||
| Q1 25 | 6.8% | -5.2% | ||
| Q4 24 | 6.9% | 4.2% | ||
| Q3 24 | 10.3% | 6.0% | ||
| Q2 24 | 10.9% | 3.2% |
每股收益（稀释后）FELESHC
| Q1 26 | $0.77 | — | ||
| Q4 25 | $0.87 | $0.12 | ||
| Q3 25 | $0.37 | $0.17 | ||
| Q2 25 | $1.31 | $0.03 | ||
| Q1 25 | $0.67 | $-0.05 | ||
| Q4 24 | $0.73 | $0.05 | ||
| Q3 24 | $1.17 | $0.06 | ||
| Q2 24 | $1.26 | $0.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $80.4M | $344.6M |
| 总债务越低越好 | $134.4M | $2.1B |
| 股东权益账面价值 | $1.3B | $606.0M |
| 总资产 | $2.0B | $3.3B |
| 负债/权益比越低杠杆越低 | 0.10× | 3.53× |
8季度趋势，按日历期对齐
现金及短期投资FELESHC
| Q1 26 | $80.4M | — | ||
| Q4 25 | $99.7M | $344.6M | ||
| Q3 25 | $102.9M | $299.2M | ||
| Q2 25 | $104.6M | $332.4M | ||
| Q1 25 | $84.0M | $304.4M | ||
| Q4 24 | $220.5M | $277.2M | ||
| Q3 24 | $106.3M | $306.7M | ||
| Q2 24 | $58.1M | $246.1M |
总债务FELESHC
| Q1 26 | $134.4M | — | ||
| Q4 25 | $135.2M | $2.1B | ||
| Q3 25 | $135.2M | $2.1B | ||
| Q2 25 | $14.5M | $2.2B | ||
| Q1 25 | $14.9M | $2.2B | ||
| Q4 24 | $11.6M | $2.2B | ||
| Q3 24 | $11.6M | $2.2B | ||
| Q2 24 | $87.2M | $2.2B |
股东权益FELESHC
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.3B | $606.0M | ||
| Q3 25 | $1.3B | $550.5M | ||
| Q2 25 | $1.3B | $511.3M | ||
| Q1 25 | $1.3B | $414.1M | ||
| Q4 24 | $1.3B | $404.9M | ||
| Q3 24 | $1.3B | $470.2M | ||
| Q2 24 | $1.2B | $422.8M |
总资产FELESHC
| Q1 26 | $2.0B | — | ||
| Q4 25 | $1.9B | $3.3B | ||
| Q3 25 | $2.0B | $3.2B | ||
| Q2 25 | $2.0B | $3.2B | ||
| Q1 25 | $1.9B | $3.1B | ||
| Q4 24 | $1.8B | $3.1B | ||
| Q3 24 | $1.8B | $3.1B | ||
| Q2 24 | $1.8B | $3.1B |
负债/权益比FELESHC
| Q1 26 | 0.10× | — | ||
| Q4 25 | 0.10× | 3.53× | ||
| Q3 25 | 0.10× | 3.89× | ||
| Q2 25 | 0.01× | 4.34× | ||
| Q1 25 | 0.01× | 5.36× | ||
| Q4 24 | 0.01× | 5.49× | ||
| Q3 24 | 0.01× | 4.73× | ||
| Q2 24 | 0.07× | 5.26× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $103.1M |
| 自由现金流经营现金流 - 资本支出 | — | $52.4M |
| 自由现金流率自由现金流/营收 | — | 17.3% |
| 资本支出强度资本支出/营收 | — | 16.7% |
| 现金转化率经营现金流/净利润 | — | 2.96× |
| 过去12个月自由现金流最近4个季度 | — | $149.2M |
8季度趋势，按日历期对齐
经营现金流FELESHC
| Q1 26 | — | — | ||
| Q4 25 | $104.2M | $103.1M | ||
| Q3 25 | $102.7M | $71.2M | ||
| Q2 25 | $51.5M | $57.4M | ||
| Q1 25 | $-19.5M | $55.5M | ||
| Q4 24 | $110.3M | $55.7M | ||
| Q3 24 | $116.1M | $97.5M | ||
| Q2 24 | $36.4M | $61.3M |
自由现金流FELESHC
| Q1 26 | — | — | ||
| Q4 25 | $88.7M | $52.4M | ||
| Q3 25 | $91.3M | $35.0M | ||
| Q2 25 | $39.9M | $26.2M | ||
| Q1 25 | $-26.3M | $35.6M | ||
| Q4 24 | $97.5M | $-10.2M | ||
| Q3 24 | $106.6M | $61.1M | ||
| Q2 24 | $26.1M | $19.4M |
自由现金流率FELESHC
| Q1 26 | — | — | ||
| Q4 25 | 17.5% | 17.3% | ||
| Q3 25 | 15.7% | 11.2% | ||
| Q2 25 | 6.8% | 8.9% | ||
| Q1 25 | -5.8% | 14.0% | ||
| Q4 24 | 20.1% | -3.5% | ||
| Q3 24 | 20.1% | 21.4% | ||
| Q2 24 | 4.8% | 7.0% |
资本支出强度FELESHC
| Q1 26 | — | — | ||
| Q4 25 | 3.1% | 16.7% | ||
| Q3 25 | 2.0% | 11.6% | ||
| Q2 25 | 2.0% | 10.6% | ||
| Q1 25 | 1.5% | 7.8% | ||
| Q4 24 | 2.6% | 22.7% | ||
| Q3 24 | 1.8% | 12.7% | ||
| Q2 24 | 1.9% | 15.2% |
现金转化率FELESHC
| Q1 26 | — | — | ||
| Q4 25 | 2.65× | 2.96× | ||
| Q3 25 | 6.14× | 1.47× | ||
| Q2 25 | 0.86× | 7.21× | ||
| Q1 25 | -0.63× | — | ||
| Q4 24 | 3.28× | 4.52× | ||
| Q3 24 | 2.13× | 5.73× | ||
| Q2 24 | 0.62× | 7.00× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FELE
暂无分部数据
SHC
| Transferred At Point In Time | $198.4M | 65% |
| Nelson Labs | $55.2M | 18% |
| Nordion | $49.8M | 16% |
